EE432 Cost-Effectiveness Analysis of Sacubitril/Valsartan in Implantable Cardioverter-Defibrillator Eligible Patients
| Autor: | Kaddoura, R, Abushanab, D, Arabi, AR, Al-Badriyeh, D |
|---|---|
| Zdroj: | In Value in Health July 2022 25(7) Supplement:S419-S419 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect